Daily subcutaneous injections of various dosages of melatonin were given early in the light phase to groups of adult male golden hamsters maintained in a long photoperiodic cycle (14 h light). This injection was followed by a second daily injection of melatonin late in the light phase at a concentration sufficient to induce reproductive organ atrophy. An afternoon injection of melatonin resulted in reproductive organ atrophy in animals that received 0, 1 or 5 µg of melatonin in the morning. However, morning injections of 25 or 100 µg of melatonin partially prevented the inhibitory effects of the afternoon injection of melatonin, and a morning injection of 500 µg of melatonin prevented the reduction of testicular weights in animals which concurrently received the afternoon injection of melatonin. Serum testosterone levels were depressed in animals that received afternoon injections of melatonin regardless of the dosage of melatonin given in the morning. The greatest concentration of melatonin given in the morning (500 µg) did not completely prevent the depressive effect of the afternoon injection of melatonin on serum testosterone. Since melatonin-induced gonadal atrophy is not prevented by a morning injection of melatonin of less than 25 µg, the data suggest that there is a lower limit of the concentration of melatonin when given in the morning that is incapable of ‘down-regulating’ the melatonin receptors to the atrophy-inducing injection of the indole given later in the photoperiod.

Keywords:
Melatonin, Pineal gland, Testes, Testosterone
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.